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1. Introduction
The inner ear is a most complicated and highly organized anatomical region that possess‐
es an elaborate system for hearing. It requires a unique structure for discriminating between
the  physical  vibrations  caused  by  various  sounds  and  specific  cellular  mechanisms  to
convert the physical sounds received into chemical signals that must be transmitted to the
brain correctly. For normal hearing, the highly optimized environment is controlled by the
concerted function of an enormous number of expressed proteins. If proteins comprising
the elements of hearing are damaged, it is possible that the normal hearing function might
be impaired.
So,  how  do  sound  waves  travel  through  the  ear  canal  and  integrate  in  the  inner  ear?
Vibrations  that  come into  contact  with  the  tympanic  membrane  travel  through the  air-
filled middle ear cavity via auditory ossicles: namely, the malleus, incus and stapes. These
ossicles  convert  lower-pressure  eardrum  sound  vibrations  into  higher-pressure  sound
vibrations at a smaller membrane called the oval window. This window is a membrane-
covered opening that leads from the middle ear to the vestibule of the inner ear or cochlea
(Figure  1a,  b,  c).  The  sound waves  are  transduced into  nerve  impulses,  which are  per‐
ceived by the temporal lobe of the brain. A core component of the cochlea is the Organ of
Corti-the sensory organ of hearing-which is distributed along the partition that separates
fluid chambers in the coiled, tapered tube of the cochlea (Figure 1d). Sound waves passing
through  the  scala  timpani  in  the  cochlea  vibrate  the  tectorial  membrane  and  stimulate
stereocillia, which are located on the periplasmic region of hair cells (Figure 2). A shear‐
ing  movement  between  the  tectorial  membrane  and  the  basilar  membrane  deflects  the
stereocilia,  affecting  tension  on  the  tip-link  filaments,  which  then  open  and  close  non-
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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specific  ion channels  [1].  When the  tension increases,  the  flow of  ions  across  the  mem‐
brane into the hair cell also rises. This is the first step of the mechanoelectrical transduction
system and causes receptor depolarization, which subsequently excites the cochlear nerve
afferents that are located at the base of the hair cell.  In the cochlea, many specific genes
such as ion channels, mechanical proteins and signal transduction-related molecules, among
others, are expressed and function in hearing [2]. In the case that more than one of these
proteins is mutated, hearing function might be impaired or lost. This is one of the main
causes of congenital hearing loss, which can be inherited.
It is widely known that deafness is a frequently inherited sensory disorder: one in every
500 new-borns has bilateral sensorineural hearing loss (SNHL) and 70% of these cases are
congenital [3, 4]. Hereditary hearing loss is classified as either syndromic or nonsyndrom‐
ic [5]. It is assumed that hearing-associated genes amount to over 400 [6]; to date, 76 genes
involved in syndromic and nonsyndromic hearing loss have been identified [7]. The genetic
causes  of  nonsyndromic  hearing  loss  are  autosomal  dominant  (27  identified  genes),
autosomal recessive (40 genes), X-chromosome-linked (three genes) and mitochondrial (six
genes) [7].
The  expression  patterns  of  genes  in  the  inner  ear  can  be  visualized  on  the  Hereditary
Hearing Loss Homepage [7].  In terms of genes associated with deafness,  many different
types of mutation have been identified, including missense, nonsense, splicing, regulato‐
ry, deletions, insertions, indels and duplications. So far, missense/nonsense mutations have
been shown to account for 55.4% of all  mutation types [2].  Identification of  phenotype–
genotype correlations is crucial for determining the aetiology of congenital hearing loss and
has implications for prognostic and therapeutic outcomes. For missense mutations in the
coding regions of  a gene,  it  is  assumed that the mechanism of hearing loss is  based on
functional disorders of the gene product. Thus, to understand congenital hearing loss it is
essential to study extensively the functions of proteins expressed in the inner ear.
Hearing levels and patterns are represented by an audiogram, which is a graph showing
the results of pure-tone hearing tests (Figure 3). Hearing loss can be categorized in terms
of which part of the auditory system is damaged. There are three basic types of hearing
loss: conductive hearing loss, SNHL and mixed hearing loss. In most cases, hearing loss is
SNHL and nonsyndromic [8]. It is clear that some correlations between hearing loss and
specific  genes are robust,  such as the low-frequency audioprofile associated with WFS1-
related  hearing  loss  [9]  and  the  mid-frequency  audioprofile  associated  with  TECTA-
related hearing loss [10]. High-frequency hearing loss, by contrast, can be the consequence
of mutations in a large number of different genes such as KCNQ4, DFNA5, COCH and
POU4F3 [9]. As part of an approach to determining how mutations of these proteins cause
dysfunction in the inner ear, analysis of their three-dimensional structures is indispensable.
Analysis of protein structures (i.e., by X-ray crystallography, NMR, cryo-EM, etc.) is very
effective  in  elucidating  the  mechanisms  of  hearing  loss.  However,  the  reported  protein
structures  that  are  related  to  hearing  loss  account  for  only  16  of  the  97,789  structures
deposited in  the  Protein  Data  Bank (PDB) [11].  Most  hearing-related proteins  are  adhe‐
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sion molecules (e.g.,  Gap junction, CDH23),  ion transporters (e.g.,  KCNQ4, SLC26A4) or
proteins involved in vesicular transport such as SNARE proteins (e.g., Otoferlin) [12, 13],
for  which  it  is  difficult  to  elucidate  the  three-dimensional  structure  owing  to  technical
difficulties such as protein expression, purification and crystallization, among others. Thus,
the protein structures of hearing-related proteins are not well elucidated.
However, it is possible to generate computer-predicted structures of disease-related proteins
if  appropriate  template  structures  are  available  in  the  PDB  and  also  to  elucidate  the
mechanism  of  protein  function  impairment  by  comparing  wild-type  and  mutant  struc‐
tures. This alternative approach has an advantage in that the association of ligands such as
sugar chains with a protein is extremely difficult to examine by crystallization, due to the
structural  mobility  of  the sugar chain,  whereas it  can be easily  investigated by docking
simulations. Thus, in silico modelling can help explain the functional impairment caused
by mutation in terms of protein structure.
In this chapter, we describe a protein, namely a voltage-gated potassium channel, which is
implicated in hearing loss. We discuss how mutants of this protein from patients cause hearing
impairment from the point of view of molecular structure. Several types of software are freely
available for these kinds of study and are useful for pharmacologists, molecular biologists and
physicians. In addition, information on the three-dimensional structure is essential for
discovering seed compounds in the field of drug design. Elucidation of structural data and the
mechanisms of functional impairment due to mutations, coupled with computer-aided drug
design, can lead to clinical benefits.
 
Figure 1. Structures of the rat’s inner ear. (a, b): Whole-mount structure of the left (a) and right (b) inner ear with
bone tissue dissected from rat. (c, d): The vestibular organ (c) and cochlea (d) extracted from bone tissues.
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 Figure 2. Schematic diagram of the coronal section of the cochlear duct. The majority of hearing loss-related genes
are expressed in the cochlea. Hereditary Hearing Loss Homepage [7]
 
Figure 3. Hearing levels expressed on an audiogram. Frequency is expressed in terms of the number of cycles per sec‐
ond, or “Hertz”. The range of most of the sounds in speech is 250Hz to 8000Hz. Loudness or “level of sound” is meas‐
ured in units called decibels (dBs). The audiogram shows hearing loss across a range of frequencies; both the hearing
level and the threshold of hearing level are indicated.
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2. The voltage-gated potassium channel KCNQ4
KCNQ4,  which encodes  the  voltage-gated potassium channel  KQT-like  subfamily  mem‐
ber  4,  has  been identified as  a  causative  gene in  hearing loss  [14].  The gene encodes  a
protein of 695 amino acid residues in its longest isoform and contains six transmembrane
a-helices, (S1–S6), a pore helix (PH), a pore-loop (P-loop), a short N-terminal region and a
long C-terminal region (Figure 4).  As in other KQT-like channels, the ion-selective chan‐
nel  formed  by  KCNQ4  comprises  a  tetramer  of  identical  subunits  in  which  the  highly
conserved P-loop of each subunit combines to form the pore structure [15]. The pore region
of  the  KCNQ4 channel  consists  of  contiguous  structures  of  S5,  PH,  P-loop  and S6  ele‐
ments. Functional and structural analyses of Kv channels have demonstrated that the PH
and the P-loop are  responsible  for  the selective K+penetration,  whereas S4 regulates  the
open-closed state of the channel as a voltage sensor [16-18].
 
Figure 4. Schematic representation of the six transmembrane helices (S1–S6) and the K+ selective channel pore re‐
gion(S5, PH, P-loop and S6) of KCNQ4. Yellow, red, orange and green circles indicate the p.Ser260del, p.Y270H,
p.G285Sand p.G287R mutations, respectively. Dark blue spheres indicate potassium ions. This figure was made with
some modification using the figure in our previous study [23].
KCNQ4 is expressed predominantly in the basolateral membrane of outer hair cells, a type of
auditory sensory cell in the cochlea (Figure 5) and plays an important role in the proper
electrophysiological function of these cells [19]. KCNQ4 is also expressed in spiral ganglion
(SG) cells, although its function in SG cells is unknown. A mouse model expressing a dominant-
negative form of KCNQ4 demonstrates hearing loss with slowly progressive degeneration of
the outer hair cells owing to chronic depolarization caused by loss of the major K+efflux
pathway [20]. The clinical features-namely, congenital, progressive high-frequency sensori‐
neural hearing loss (Figure 6) without substantial loss of speech recognition during the first
decade of life-exhibit a very strong hereditary tendency for patients with mutated KCNQ4
proteins [21, 22]. Since patients with KCNQ4 mutations show progressive hearing loss, the
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development of a drug to improve the function of the KCNQ4 channel might attenuate the
symptoms.
Figure 5. Expression pattern of the KCNQ4 channel in the cochlea. Protein expression is indicated in purple.
We identified two disease-associated mutations of KCNQ4: in one, a tyrosine residue (Tyr270)
is replaced with histidine (His); and in the other, there is a deletion, c.806_808delCCT, leading
to a p.Ser260del located between S5 and the pore helix (PH) in the gene product of KCNQ4 [23,
24]. We then generated a computational structural model of the KCNQ4 channel by referring
to the crystal structure of the Shaker family K+channel, Kv1.2 [23, 24]. In the following sections,
we speculate about the molecular mechanism underlying hearing loss according to the basic
quantum chemistry of a KCNQ4 channel formed with the Tyr270His (p.Y270H) and
p.Ser260del (p.S269del) mutations and we discuss how two more severe mutations-
p.Gly285Ser (p.G285S) [14] and p.Gly287Arg (p.G287R) [25]-might cause severe to profound
hearing loss from a structural point of view.
3. Materials and methods
3.1. Genetic analysis
Initially, KCNQ4 was selected as a candidate gene involved in hearing loss on the basis of
clinical features [26]. Prior to this study, the patient was confirmed to have neither GJB2
mutations, the most common causative gene of hereditary hearing loss, nor the mitochondrial
m.1555A > G and m.3243A > G mutations. Genomic DNA was extracted from blood samples
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via the Gentra Puregene Blood Kit (QIAGEN, Hamburg, Germany). PCR primers specific for
KCNQ4 were designed in our laboratory [23].
3.2. Molecular modelling of KCNQ4
A series of molecular modelling was conducted by the following procedures.
1. PDBsum: To find structural relatives of KCNQ4 for molecular modelling, we utilized
PDBsum [27] and Gapped BLAST [28] in an attempt to search for the protein that is most
homologous in amino acid sequence to the full length of KCNQ4 and that has a macro‐
molecular structure deposited in the Protein Data Bank.
2. Swiss-Model: Among the channels with available three-dimensional structures, the
sequence of Kv1.2 was most similar to that of KCNQ4 (27.5% identity for the transmem‐
brane sequence Ser32 to Thr417). The transmembrane domains (S1–S6) including the
voltage sensor and the pore region of KCNQ4 (Tyr80 to Gln329) and its Tyr270His and
p.Ser260del mutants were modelled using the fully automated protein structure model‐
ling server Swiss-Model [29-31] and the crystal structure of Kv1.2 (PDB ID: 3LUT, chain
B) as a template [17]. The structural model of KCNQ4 was calculated by automatic
modelling mode with default conditions.
 
Figure 6. An audiogram from a patient with the KCNQ4 Tyr270His mutation [23]. Open circles indicate the hearing
levels of air conduction for the right ear. Crosses indicate the hearing levels of air conduction for the left ear. “[” and
“]” indicate the hearing levels of bone conductions in the right and left ear, respectively. In conductive hearing loss,
the bone conduction hearing thresholds are normal but there is a loss of hearing for air conduction sounds. This
means that the cochlea is normal, but there is a blockage to sound in the middle or outer ear. This audiogram shows
that the patient has sensorineural hearing loss (SNHL) because the hearing pattern of air conduction is close to that of
the bone conductions.
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3. Verify_3D Structure Evaluation Server: The quality of the structural model was evalu‐
ated by Verify_3D [32-34] and was found to be trustworthy [23].
4. UCSF Chimera: The structural models of KCNQ4 and the Tyr270His, p.Ser260del,
p.G285S and p.G287R mutants were fitted into the corresponding transmembrane
domains of the Kv1.2 structure and UCSF Chimera [35] was used to visualize the putative
structure by α-carbon frame or by ribbon model with electric surface potentials.
Figure 7. Sequence alignment of KCNQ4 proteins. (a) Sequence alignment of the orthologous KCNQ4 pore region.
Positions highlighted in light blue indicate that the amino acid is identical to that in human KCNQ4. The position of
Ser269 and Tyr270 is boxed in red and Tyr270 is indicated by an arrow. The positions of Gly285 and Gly287 are high‐
lighted in yellow and orange, respectively. The positions of S5, PH, S6 (wavy lines) and the P-loop (straight line) are
indicated below the sequences. (b) Alignment of the KCNQ4 pore-region sequence with those of Kv channels deposit‐
ed in the PDB. Positions highlighted in green indicate that the amino acid is identical to that in human KCNQ4. The
sequence of human KCNQ4 is indicated at the top of both alignments. This figure was made with some modification
using the figure in our previous study [23].
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4. Results and discussion
To date, 21 missense mutations, a splice-site mutation and four small deletion mutations in
KCNQ4 have been reported to be associated with hearing loss [36]. Eleven of the missense
mutations are located in the pore region; thus, these mutations are considered to be pathogenic
[14, 21, 23, 24, 37, 38]. As mentioned above, KCNQ4 contains six transmembrane a-helices, (S1–
S6), a pore helix (PH), a pore-loop (P-loop), a short N-terminal region and a long C-terminal
region (Figure 4). The pore regions of Kv channels are formed by contiguous S5, PH, P-loop
and S6 regions. Functional and structural characterizations of Kv channels have demonstrated
that the PH and P-loop are responsible for selective K+transport, whereas S4, acting as a voltage
sensor, regulates the open–closed state of the channel [17, 18]. Tyr270 and Ser269 are predicted
to be the N-terminal residues of the PH.
Among the mammalian KCNQ4 sequences that are available, the pore-region sequences are
identical and those of non-mammals (e.g., birds, fruit flies, tunicates and nematodes) are very
similar to the mammalian sequences (Figure 7a). In addition, the PH and P-loop sequences of
non-KCNQ4 Kv channels are somewhat conserved (e.g., Kv2.1 from Homo sapiens is identical
in 14/24 amino acid residues, Kv1.2 from Rattus norvegicus in 11/24 residues and KvAP, a
prokaryotic Kv channel from Aeropyrum pernix, in 13/24 residues). In addition, the positions
of Gly285 and Gly287 on the P-loop are fully conserved across mammalian and non-mamma‐
lian KCNQ4 sequences. These commonly mutated residues are thought to be important for
proper functioning of the channel (Figure 7a).
Tyr270, at the N-terminus of PH, is located at the same position as the corresponding Kv1.2
residue (Ile361) (Figure 7b). Gly285 and Gly287 are also fully conserved in Kv channels. We
therefore assessed the electrostatic characteristics of structural models containing mutations
of these residues to determine whether these residues might be responsible for the patient’s
hearing loss.
4.1. p.Y270H mutation
The ribbon model of wild-type KCNQ4 with the electrostatic surface potential superimposed
suggests that the side chain of Tyr270 (coloured white in Figure 8a) should be electrostatically
neutral. For Tyr270His, by contrast, the side chain of His270 (coloured blue in Figure 8b) is
predicted to retain at least a partial positive charge, which reflects the standard pKa value (6.5)
for histidine.
Moreover, His270 is surrounded by the negatively charged residues Asp272, Asp266, Asp262
and Glu260, as well as the polar residues Ser269, Ser268 and Ser265, which are capable of
hydrogen bonding (all of these residues are within 10 Å of His270, Figure 8c). In haemoglobin
(PDB ID: 2hhb), the side-chain pKa of His97, which is surrounded by two negatively-charged
asparagine residues within five Å distance, is shifted to an abnormally high value (pKa=7.8)
[39]. For these reasons, the side chain of His270 may also have a pK value that is greater than
the standard value; therefore, it is predicted that more than half of the histidine side chains at
position 270 carry a positive charge at near physiological pH (Figure 8b).
Molecular Modelling-Based Investigations of a Mutant Protein in Patients with Hearing Loss
http://dx.doi.org/10.5772/58398
11
Alteration of the electrostatic surface potential of a single helical residue in the pore region
might affect the structural stability of the channel as a consequence of a change in the helix
dipole moment. A substantial dipole moment with positive and negative unit charges at,
respectively, the N-and C-terminus of an α-helix is often found (Hol, 1985). A comparison of
three Kv channel structures suggests that the dipoles of the transmembrane helices orient the
helices and are responsible, at least in part, for the structure of the pore [15, 40, 41]. The
electrically neutral Tyr270, which, as noted above, is positioned at the N-terminus of the PH,
is located within 9 Å of Ala263 at the C-terminus of S5 (Figure 8a, b). The presence of a
positively-charged histidine residue adjacent to, or at the N-terminal of, an α-helix can
destabilize the helix dipole [42]. Replacement of Tyr270 with histidine may therefore increase
the dipole moment of the PH.
Alternatively, or in conjunction with the destabilization effect, His270 may impede K+trans‐
port. The electrostatic repulsion between positively-charged His270 and K+would be stronger
than that between electrically-neutral Tyr270 and K+. In the p.Y270H model, the distance
between His270 and the centre pore of the channel is ~20.5 Å (Figure 8d, e). This distance is
small enough to affect the electrostatic interaction between two charged molecules in a non-
polar environment (e.g., the interior of a membrane protein) because the electrostatic force is
strong and affects charges separated by 500–1800 Å [43-45]. In addition, the dielectric constants
in the interior of a protein and in a lipid membrane are assumed to be five and two, respectively,
whereas that of bulk water is ~80 at room temperature [46], a value that can be elicited by basic
Coulomb’s law (see Formula). The electrostatic potential energy for two charges in protein or
lipid membrane interiors is therefore between 16 and 40 times greater than that in water.
Consequently, the long-range electrostatic repulsive force between positively charged His270
and a K+ion might possibly impede passage of K+through the channel [47], whereas the force
on K+would be smaller in the extracellular region.
Several mutations in the PH of KCNQ4 (e.g., Leu274His and Trp276Ser) have been correlated
with hearing loss [21]. Interestingly, ectopic expression of both the Trp276Ser mutant and wild-
type KCNQ4 in a cultured cell line caused a reduction in the channel current, whereas
expression of the mutant alone caused impaired trafficking of the protein to the cellular
membrane [48]. The similar clinical symptoms and locations of the mutations within KCNQ4
support the proposal that p.Y270H is a pathogenic mutation associated with progressive
SNHL. Further physiological and three-dimensional structural characterization of the
p.Y270H KCNQ4 protein may identify which of our working hypotheses-namely, structural
distortion of the channel caused by a change in the dipole moment of the PH or electrostatic
impediment of K+transport (or both)-causes hearing loss in the patient and may provide insight
into how to reverse hearing loss caused by KCNQ4 mutations.
Formula: (1) The electrostatic repulsive interactions in the pore region can be explained by
classic Coulomb’s law. Tyr270 in KCNQ4 is neutrally charged, whereas His270 in the
Tyr270His mutation is predicted to be positively charged (at physiological pH 7.4). Thus, extra
electrostatic repulsion force (q) is generated between His270 and K+, which is more intense
than that between Tyr270 and K+.
Pharmacology and Therapeutics12
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Figure 8. Structural models of KCNQ4 and the Tyr270His mutant. (a, b) Part of the wild-type KCNQ4 model (a) and the
Tyr270His model (b) overlaid with their corresponding electrostatic surface potentials. Arrows indicate the side chains
of Tyr270 (a) and His270 (b). Blue, red and white indicate positively-charged, negatively-charged and neutral atoms,
respectively. (c) Ribbon model of the Tyr270His pore region. Residues surrounding His270 that are negatively-charged
or that can form a hydrogen bond are shown in red. (d, e) Superimposition of the Tyr270His ribbon model onto a
horizontal view of the plasma membrane (d) and an extracellular view (e) with the four rotational axes of the Kv1.2
crystal structure shown as a hydrophobicity surface. Hydrophobic and hydrophilic residues are indicated in red and
blue, respectively, in the hydrophobicity surface representations. His270 is shown in yellow. K+ in the central pore is
shown as a purple sphere in a–e and indicated by an arrow in e. This figure was made with some modification using
the figure in our previous study [23].
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(2) The electrostatic potential energy (E) between His270 and K+is affected by the dielectric
constant (ε).
4
i j
i j ij
q qE rpe<
=å (2)
(3) Assuming that the K+ion is within the pore region of the K+channel, the ε value is 5, whereas
in water, the ε value is 80. Therefore, the electric repulsive force would be much more intense
between His270 and K+within the pore region of the K+channel than in the extracellular space.
4 5 4 80
H K H Kpore water
i j i jij ij
q q q qE Er rp p
+ +
< <
= >> =å å (3)
(4) The Van der Waals potential energy (V) between His270 and K+can be ignored because it
is extremely weak as compared with the electrostatic force. This energy decays exponentially
with the internuclear distance (r). A and B represent the repulsive and attractive constant,
respectively.
( ) 12 6r
A BV r r= - (4)
 
Figure 9. Partial structural model of KCNQ4 and the p.Ser269del mutation. (a, b) Ribbon models of the wild-type
KCNQ4 subunit (a) and the KCNQ4 subunit with the p.Ser269del mutation (b) overlaid with their corresponding elec‐
trostatic surface potential. Red or blue areas indicate negatively-or positively-charged residues, respectively; yellow
dots indicate the negatively-charged surface potential on the N-terminal region of the PH; pale yellow lines indicate
hydrogen bonds and yellow arrows indicate hydrogen bonds within S5 and PH. This figure was made with some mod‐
ification using the figure in our previous study [24].
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4.2. p.Ser269del mutation
The ribbon model of the wild-type KCNQ4 subunit overlaid with the corresponding electro‐
static surface potential demonstrates that the surface of the N-terminal region of the PH is
negatively charged owing to the negatively-charged side chains of Ser269 and Asp272 (Figure
9a). The model of KCNQ4 with the p.Ser269del mutation demonstrates a reduction in the
negatively-charged surface area in this region (Figure 9b). In case of the p.Y270H mutation,
reducing the electrostatic surface potential in this area is predicted to impede K+transport
owing to the long-range electrostatic force between the PH and K+(Formula).
In addition, hydrogen bonds at the C-terminus of S5 and the N-terminus of the PH of wild-
type KCNQ4 (Figure 9a, yellow arrows) are absent in Ser269del KCNQ4 (Figure 9b). Loss of
the hydrogen bonds around the N-terminus of the PH results in shortening of the PH and has
been attributed to the destabilization of a-helix formation, resulting in a change in the helix
dipole moment [39]. A change in dipole moment in this case might also destabilize the pore
region structure, which is also likely to impede K+transport. Overall, the molecular impairment
is likely to be a mild dominant-negative effect, resulting from the relatively small influence of
the p.Ser269del mutation on the normal KCNQ4 channel subunit.
4.3. p.G285S and p.G287R mutations
Of particular importance in the P-loop are the three amino acids GYG, which are highly
conserved in the Kv channel family (Figure 7b). The structure derived from molecular
modelling reveals that the GYG residues (Gly285 and Gly287) bind directly to K+and this
electric static level is an integral part in the normal function of K+penetration. In the p.G285S
mutant structure, the electrostatic value of glycine is very similar to that of serine; however,
the side chain of serine is polarized (Figure 10a, b: yellow arrow). This side chain protrusion
of serine changes the normal structure of the central route of K+, providing decisive evidence
of the impediment of K+transport. In support of this, the current measured by electrophysio‐
logical examination in Xenopus oocytes was markedly reduced by the dominant-negative effect
of p.G285S as compared with wild type [14].
The pKa value for Arg (12.48) is positively charged in normal periplasmic environment and
generates a strong repulsive force between Arg287 and K+(Figure 10c). In addition, the side
chain of Arg287 protrudes into the K+position, resulting in complete blockage of the passage
of K+. Thus, the effect of the p.G287R mutation is much stronger than that of the p.G287S
mutation, from the structural analysis data. However, the hearing levels and patterns of
patients with the p.G285S and p.G287R mutations are very similar [14, 25].
At the genetic level, KCNQ4 channels with missense mutations are predicted to act via a
dominant-negative mechanism to induce progressive, predominantly high-frequency hearing
loss [14]. In families with deletions that lead to frameshifts and stop codons, however, the
phenotype is characterized by better low-frequency deterioration, but more rapid high-
frequency deterioration [22, 49]. In addition, it is thought that truncating mutations such as
p.Gln71SerfsX138 and p.Gln71fs on heterozygous alleles are probably not synthesized from
these alleles and functional impairment is considered to be due to haploinsufficiency [24, 37,
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50]. Missense mutations are usually translated into protein, whereas nonsense and large
truncating mutations are not. For a heteromeric missense mutation of KCNQ4, incomplete
tetramers might be generated; however, the functional structure of KCNQ4 is a tetramer of
protein subunits. If one mutated subunit is integrated in the tetramer, the function of the K
+transportation will be lost, even though three subunits are still normal. Thus, a dominant-
negative effect occurs. In the case of haploinsufficiency, a normal tetramer of KCNQ4 will be
expressed, although the allelic expression is 50% of the normal value. These possibilities
indicate that differences in hearing patterns and levels might occur between missense and
nonsense (or large deletion) mutations.
 
Figure 10. Structural model of the centre pore region of KCNQ4. The wild-type KCNQ4 (a), the p.G285S mutation (b)
and the p.G287R mutation (c) models are overlaid with their corresponding electrostatic surface potentials. The side
chains of Ser285 (b) and Arg287 (c) are indicated by arrows. The periplasmic region is at the top.
5. Conclusion
From our structural analysis, KCNQ4 is a transporter that has been refined during protein
evolution. To develop molecular drugs targeted at, for example, the pore region of KCNQ4, it
is necessary to take a special approach other than the normal screening of seed compounds as
candidate inhibitors of a pathogenesis factor. Considering the molecular interpretation
described in this chapter, it seems that there are two approaches to the development of drugs
that might act on mutations in the P-loop in a target. The first is a drug that acts on the P-loop
directly. However, it is presumed that the development of drugs directly targeting the P-loop
would be somewhat difficult because the P-loop is hypersusceptible and there is no space in
the centre pore for K+passage. The second and ideal approach is to screen for compounds that
act on mutations on the P-loop at long range, taking into consideration our p.Y270H mutation
model. It is hoped that such a drug that can control the penetration of ions from a remote
position might be developed in future studies. In this chapter, we have described a case of
structural impairment caused by KCNQ4 mutation. Elucidation of the impairment mechanism
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underlying missense mutations and the strategy of drug design will be applicable to the
development of therapies for many genetic illnesses.
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